While Mediations And Negotiations Continue, The First Scheduled YAZ / Yasmin Trials In Federal And State Courts Are Postponed Indefinitely
July 2012 Litigation Update: Almost 2000 Bayer Settlements For Gianvi / Ocella / Yasmin / YAZ Lawsuits Involving Blood-Clot Side Effects Like Deep Vein Thrombosis (DVT) And Pulmonary Embolism (PE)______________________________________________________________________________
In late April 2012 Bayer announced that it has settled lawsuits involving YAZ and Yasmin side effects related to blood clots, namely deep vein thrombosis (DVT) and pulmonary embolism (PE) cases.
From an April 26, 2012 Bloomberg news report, "Bayer Yasmin Lawsuit Settlements Climb to $142 Million":
Bayer, based in Leverkusen, Germany, has resolved 651 cases alleging its Yasmin and Yaz contraceptives caused sometimes-fatal clots that can lead to heart attacks and strokes, the company said today in its Stockholders’ Newsletter for the first quarter. The company said it paid $142 million in the settlements....
“Bayer is only settling claims in the U.S. for venous clot injuries (deep vein thrombosis or pulmonary embolism) after a case specific analysis of medical records,” the company said in the report.
The Yasmin and YAZ lawsuits filed in the federal court system are consolidated before U.S. District Judge David Herndon in the case In re Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Product Liability Litigation, 09-md-02100, U.S. District Court, Southern District of Illinois (East St. Louis), which is commonly referred to as the Yasmin and YAZ MDL, where the majority of these cases are pending.
There are also state court consolidations for Yasmin and YAZ lawsuits filed in New Jersey and Pennsylvania.
Free Case Evaluation
Strictly Confidential, No Obligation.
Judge Herndon as well as the NJ and PA state court judges have postponed indefinitely the so-called "bellwether", or test case, trials that were suppose to begin this year while Bayer attempts to reach settlements with the thousands of women who suffered a DVT and/or PE while using Yasmin or YAZ. If the mediations and negotiations to settle those lawsuits are not successful, it is likely the respective judges will set new starting dates for the first YAZ and Yasmin court trials.
At the present time, the fate of thousands of gallbladder removal cases is uncertain, with Bayer not discussing settlement of those YAZ and Yasmin lawsuits but with gallbladder (GB) trials included on the original set of first bellwether trials scheduled in the federal court MDL proceeding and the Pennsylvania state court consolidation.
DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects
Drug Injury Case Evaluation - Free & Confidential